Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Masitinib for the treatment of mild to moderate Alzheimer's disease.
Folch J, Petrov D, Ettcheto M, Pedrós I, Abad S, Beas-Zarate C, Lazarowski A, Marin M, Olloquequi J, Auladell C, Camins A. Folch J, et al. Expert Rev Neurother. 2015 Jun;15(6):587-96. doi: 10.1586/14737175.2015.1045419. Epub 2015 May 11. Expert Rev Neurother. 2015. PMID: 25961655 Review.
Mavoglurant as a treatment for Parkinson's disease.
Petrov D, Pedros I, de Lemos ML, Pallàs M, Canudas AM, Lazarowski A, Beas-Zarate C, Auladell C, Folch J, Camins A. Petrov D, et al. Expert Opin Investig Drugs. 2014 Aug;23(8):1165-79. doi: 10.1517/13543784.2014.931370. Epub 2014 Jun 24. Expert Opin Investig Drugs. 2014. PMID: 24960254 Review.
Current Research Therapeutic Strategies for Alzheimer's Disease Treatment.
Folch J, Petrov D, Ettcheto M, Abad S, Sánchez-López E, García ML, Olloquequi J, Beas-Zarate C, Auladell C, Camins A. Folch J, et al. Neural Plast. 2016;2016:8501693. doi: 10.1155/2016/8501693. Epub 2016 Jan 3. Neural Plast. 2016. PMID: 26881137 Free PMC article. Review.
Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.
Folch J, Busquets O, Ettcheto M, Sánchez-López E, Castro-Torres RD, Verdaguer E, Garcia ML, Olloquequi J, Casadesús G, Beas-Zarate C, Pelegri C, Vilaplana J, Auladell C, Camins A. Folch J, et al. J Alzheimers Dis. 2018;62(3):1223-1240. doi: 10.3233/JAD-170672. J Alzheimers Dis. 2018. PMID: 29254093 Free PMC article. Review.
A metabolic perspective of late onset Alzheimer's disease.
Ettcheto M, Cano A, Busquets O, Manzine PR, Sánchez-López E, Castro-Torres RD, Beas-Zarate C, Verdaguer E, García ML, Olloquequi J, Auladell C, Folch J, Camins A. Ettcheto M, et al. Pharmacol Res. 2019 Jul;145:104255. doi: 10.1016/j.phrs.2019.104255. Epub 2019 May 7. Pharmacol Res. 2019. PMID: 31075308 Free article. Review.
Impact of New Drugs for Therapeutic Intervention in Alzheimer's Disease.
Olloquequi J, Ettcheto M, Cano A, Sanchez-López E, Carrasco M, Espinosa T, Beas-Zarate C, Gudiño-Cabrera G, Ureña-Guerrero ME, Verdaguer E, Folch J, Auladell C, Camins A. Olloquequi J, et al. Among authors: beas zarate c. Front Biosci (Landmark Ed). 2022 May 6;27(5):146. doi: 10.31083/j.fbl2705146. Front Biosci (Landmark Ed). 2022. PMID: 35638413 Free article. Review.
PI3 k/akt inhibition induces apoptosis through p38 activation in neurons.
Vázquez de la Torre A, Junyent F, Folch J, Pelegrí C, Vilaplana J, Auladell C, Beas-Zarate C, Pallàs M, Verdaguer E, Camins A. Vázquez de la Torre A, et al. Pharmacol Res. 2013 Apr;70(1):116-25. doi: 10.1016/j.phrs.2013.01.007. Epub 2013 Feb 1. Pharmacol Res. 2013. PMID: 23376356
136 results